Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Richter Themis Medicare is a strategic joint venture between the Hungarian pharmaceutical leader Gedeon Richter and the Indian firm Themis Medicare. The company specializes in the research, development, and large-scale manufacturing of complex steroid and hormonal Active Pharmaceutical Ingredients (APIs). Operating from a state-of-the-art facility in Vapi, Gujarat, the venture leverages Gedeon Richter's global expertise in steroid chemistry and Themis Medicare's cost-efficient manufacturing capabilities in India. Its product portfolio primarily serves the global market for oral contraceptives and hormone replacement therapies, featuring key ingredients such as ethinylestradiol and gestodene. The company's manufacturing processes are designed to meet rigorous international regulatory standards, including EU-GMP compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Richter Themis Medicare.